Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Perspective Therapeutics, Inc. | 50,000 | reported | 02 Mar 2026 | tx 2+125,000 |
| Mirati Therapeutics, Inc. | 0 | reported | 23 Jan 2024 | tx 29+78,136−68,293 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 03 Sept 2025 | GRANT_AWARD | Perspective Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 6,021 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 4,444 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 6,808 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 11,000 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 7,520 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 17,500 | — | deriv |
| 29 Dec 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 6,808 | 58.75 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 4,444 | 0.00 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 7,520 | 0.00 USD | deriv |
| 14 Jan 2022 | GRANT_AWARD | Mirati Therapeutics, Inc. | 2,546 | 0.00 USD | |
| 14 Jan 2022 | GRANT_AWARD | Mirati Therapeutics, Inc. | 3,688 | 0.00 USD | deriv |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 719 | 200.05 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 462 | 200.90 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 960 | 201.99 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 1,579 | 203.43 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 1,205 | 204.43 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 975 | 205.26 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 1,100 | 206.63 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 200 | 207.83 USD | |
| 29 Jan 2021 | EXERCISE | Mirati Therapeutics, Inc. | 7,500 | 39.76 USD | |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 50 | 197.14 USD | anomaly |
| 29 Jan 2021 | SALE | Mirati Therapeutics, Inc. | 250 | 198.48 USD | |
| 29 Jan 2021 | EXERCISE | Mirati Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |